Nuts and Bolts of The Thyroid Gland: Therapeutic Targets by Sarah Zielsdorf, MD (2021 Conference) (LDN, low dose naltrexone)

Mast Cell Activation Syndrome (MCAS) - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

Drug Resistant Depression - Elizabeth Livengood, NMD (2021 Conference) (LDN, low dose naltrexone)

Dr. Elizabeth Livengood’s presentation is on identifying different causes of depression, identifying depression, hyperthyroidism connections, identifying patient profiles who fit these descriptions, and understanding how to treat them. 

Erectile Dysfunction Therapies - Yusuf, Saleeby, MD (2021 Conference) (LDN, low dose naltrexone)

The role of immune modulation in cancer - Professor Angus Dalgleish (2021 Conference) (LDN, low dose naltrexone)

Hypothyroidism Variants - Elizabeth Livengood, NMD (2021 Conference) (LDN, low dose naltrexone)

Psoriasis - Pamela Smith, MD, MS (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

Pain - Samyadev Datta, MD (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

Early Biomarkers of a Brain on Fire - Tom O’Bryan, DC, CCN, DACBN (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

Wiebke Pape, MD - A Medication to Gain Self-Awareness: Treatment of Dissociative Symptoms in Trauma-Related Disorder II (2017 Conference) (LDN, low dose naltrexone)